Dachauer v. NBTY, Inc.’s Empirical Analysis
913 F.3d 844 · 2019
Citation profile
Relationships
Applies 21 U.S.C. § 301 (Animal Drug Amendments of 1968) · 21 U.S.C. § 343 (Federal Food, Drug, and Cosmetic Act) · 21 U.S.C. § 343 (Federal Food, Drug, and Cosmetic Act)
Relies on 27 Cal. 4th 939 - Kasky v. Nike, Inc. · 27 Cal. 4th 939 - Kasky v. Nike, Inc. · Albino v. Baca · Williams v. Gerber Products Co. · 107 Cal. App. 4th 1336 - National Council Against Health Fraud, Inc. v. King Bio Pharmaceuticals, Inc.
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 6 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
“substantiation that [the claim] is truthful and not misleading.”
1 later decision quote this exact passage · from the majority“claim[s] of the type described in section 343(r)(1).”
1 later decision quote this exact passage · from the majority
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.